Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
France Biolead’s ambition is to structure and manage a unique biomedical biomanufacturing sector , making France a European leader in biomanufacturing and guaranteeing patients better access to tomorrow’s therapeutic innovations.
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.
We are excited to share that HTL Biotechnology is present at the AMWC 2025 in Monaco.
On March 10 to 12, 2025, HTL Biotechnology was proud to be present at CIBE (China International Beauty Expo) in Guangzhou, reaffirming our commitment to the dermatology and beauty industries.